European Centre for Disease Prevention and Control

Established by EU regulation on 28 September 2004, the European Centre for Disease Prevention and Control occupies a narrow but consequential niche: it watches infectious disease across a continent of some 450 million people and tells governments what it sees. The agency began operating from Stockholm in 2005, a year after the legal text was agreed, and its founding is inseparable from the 2003 SARS outbreak, which demonstrated how quickly a novel pathogen could travel between countries with no shared early-warning system in place.

The ECDC's remit covers more than 50 infectious disease topics. Its staff collect and analyse surveillance data, run epidemic intelligence to detect outbreaks as they emerge, produce scientific risk assessments, coordinate microbiology and reference laboratories, support preparedness planning, and train field epidemiologists through the ECDC Fellowship Programme, formerly known as EPIET and EUPHEM. It publishes Eurosurveillance, a peer-reviewed journal covering surveillance, epidemiology, prevention and control, and maintains practical tools such as the ECDC Vaccine Scheduler.

Governance rests with a Management Board drawn from EU member states, the European Commission and the European Parliament, which approves the annual work programme and budget. The agency is financed from the EU budget and has no revenue, valuation or commercial ownership. Its authority is advisory rather than regulatory: it convenes, publishes and recommends, while member states retain control over their own public health measures. The closest functional analogue is the US Centers for Disease Control and Prevention, though the ECDC does not approve medicines or impose restrictions.

Communications are deliberately technical. Risk assessments, surveillance bulletins and journal papers form the bulk of its output, distributed through its website and accounts on X, Facebook, Instagram, LinkedIn and YouTube. Public awareness rose sharply during COVID-19, when variant tracking and risk assessments became daily news. In October 2026 the agency was managing several stories at once: Ebola activity in Africa, with importation risk to Europe assessed as very low; the first human case of Shamonda virus, a livestock-related arbovirus, identified in France; and record-high West Nile virus infections across Europe, with 141 deaths reported for the year. [edit]